Press Release Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM 20 October 2025
Press Release Redefines the Future of TV: SKYWORTH Unveils All-New Matte Screen Ultra TV Series at the 138th Canton Fair 20 October 2025
Press Release Xinhua Silk Road: Financial Street Forum annual conference to be held on Oct. 27-30 in Beijing 20 October 2025
Press Release Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability 20 October 2025
Press Release CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025 20 October 2025
Press Release Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity 20 October 2025
Press Release Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances 19 October 2025
Press Release HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet 19 October 2025
Press Release iOncologi Secures Foundational U.S. Patent as Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival with Cancer Immunotherapy 19 October 2025
